The effect of macrolides on myofibroblast differentiation and collagen production in nasal polyp-derived fibroblasts

American Journal of Rhinology and Allergy

Volumn 24, Issue 5, 2010, Pages 348-353

  Park, Hyo Hyun ^a   Park, Il Ho ^a   Cho, Jung Sun ^a   Lee, You Mi ^a   Lee, Heung Man ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; ERYTHROMYCIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; ROXITHROMYCIN; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MYOFIBROBLAST; NOSE POLYP; PROTEIN EXPRESSION;

ACTINS; ADULT; ANTI-BACTERIAL AGENTS; CELL DIFFERENTIATION; CELLS, CULTURED; COLLAGEN; ERYTHROMYCIN; FEMALE; FIBROBLASTS; HUMANS; MALE; MYOFIBROBLASTS; NADPH OXIDASE; NASAL POLYPS; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; ROXITHROMYCIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77957585319     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2010.24.3520     Document Type: Article

References (20)

1. Cervin A. The anti-inflammatory effect of erythromycin and its derivatives, with special reference to nasal polyposis and chronic sinusitis. Acta Otolaryngol 121:83-92, 2001. (Pubitemid 32205030)
2. Pawankar R. Nasal polyposis: An update: editorial review. Curr Opin Allergy Clin Immunol 3:1-6, 2003.
3. Serpero L, Petecchia L, Sabatini F, et al. The effect of transforming growth factor (TGF)-beta1 and (TGF)-beta2 on nasal polyp fibroblast activities involved upper airway remodeling: Modulation by fluticasone propionate. Immunol Lett 105:61-67, 2006. (Pubitemid 43674135)
4. Little SC, Early SB, Woodard CR, et al. Dual action of TGF-beta1 on nasal-polyp derived fibroblasts. Laryngoscope 118:320-324, 2008.
5. Cucoranu I, Clempus R, Dikalova A, et al. NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ Res 97:900-907, 2005. (Pubitemid 41552675)
6. Ihn H. Autocrine TGF-beta signaling in the pathogenesis of systemic sclerosis. J Dermatol Sci 49:103-113, 2008. (Pubitemid 350298736)
7. Yamabe H, Shimada M, Kaizuka M, et al. Roxithromycin inhibits transforming growth factor-beta production by cultured human mesangial cells. Nephrology (Carlton) 11:524-530, 2006.
8. Sturrock A, Cahill B, Norman K, et al. Transforming growth factor-beta1 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 290:661-673, 2006.
9. Kapoun AM, Gaspar NJ, Wang Y, et al. Transforming growth factor-beta receptor type 1 (TGFbetaRI) kinase activity but not p38 activation is required for TGFbetaRI-induced myofibroblast differentiation and profibrotic gene expression. Mol Pharmacol 70:518-531, 2006.
10. Rocic P, and Lucchesi PA. NAD(P)H oxidases and TGF-beta-induced cardiac fibroblast differentiation: Nox-4 gets Smad. Circ Res 97:850-852, 2005. (Pubitemid 41552669)
11. Ou XM, Feng YL, Wen FQ, et al. Macrolides attenuate mucus hypersecretion in rat airways through inactivation of NF-kappaB. Respirology 13:63-72, 2008.
12. Nonaka M, Pawankar R, Tomiyama S, and Yagi T. A macrolide antibiotic, roxithromycin, inhibits the growth of nasal polyp fibroblasts. Am J Rhinol 13:267-272, 1999.
13. Maizumi N, Tamura Y, Kanai H, and Tsutsui T. Quantitative comparison of the cytocidal effect of seven macrolide antibiotics on human periodontal ligament fibroblasts. J Periodontal Res 37:250-254, 2002.
14. Woo HJ, Bae CH, Song SY, et al. Expression of glutaredoxin-1 in nasal polyps and airway epithelial cells. Am J Rhinol Allergy 23:288-293, 2009.
15. Moon JH, Kim TH, Lee HM, et al. Overexpression of the superoxide anion and NADPH oxidase isoforms 1 and 4 (NOX1 and NOX4) in allergic nasal mucosa. Am J Rhinol Allergy 23:370-376, 2009.
16. Matsune S, Sun D, Ohori J, et al. Inhibition of vascular endothelial growth factor by macrolides in cultured fibroblasts from nasal polyps. Laryngoscope 115:1953-1956, 2005.
17. Suzaki H, Asano K, Yu M, and Hisamitsu T. Influence of roxithromycin on inflammatory cytokine production from nasal polyp fibroblasts in vitro. Acta Otolaryngol 123:637-642, 2003. (Pubitemid 36831381)
18. Kanai K, Asano K, Hisamitsu T, and Suzaki H. Suppression of matrix metalloproteinase production from nasal fibroblasts by macrolide antibiotics in vitro. Eur Respir J 23:671-678, 2004. (Pubitemid 38618134)
19. Jain A, Sangal L, Basal E, et al. Anti-inflammatory effects of erythromycin and tetracycline on Propionibacterium acnes induced production of chemotactic factors and reactive oxygen species by human neutrophils. Dermatol Online J 8:2, 2002.
20. Asano K, Kamakazu K, Hisamitsu T, and Suzaki H. Suppressive activity of macrolide antibiotics on nitric oxide production from nasal polyp fibroblasts in vitro. Acta Otolaryngol 123:1064-1069, 2003. (Pubitemid 38021523)